Skip to main content

Table 2 Variables (based on eyes)

From: Effect of age on response to anti-VEGF agents in patients with center involving diabetic macular edema in a tertiary hospital

 

 ≤ 60 years = 86

 > 60 years = 124

Total = 210

p-value

No DR

0 (0)

4 (3.2)

4 (1.9)

0.1575

Mild NPDR

14 (16.3)

14 (11.3)

28 (13.3)

0.1575

Moderate NPDR

33 (38.4)

68 (54.8)

101 (48.1)

0.1575

Severe NPDR

16 (18.6)

16 (12.9)

32 (15.2)

0.1575

PDR

23 (26.7)

22 (17.7)

45 (21.4)

0.1575

Focal laser

24 (27.9)

28 (22.6)

52 (24.8)

0.4086

Injection to OCT interval, mean (SD)

10.1 (6.75)

13.4 (14.60)

12.0 (12.11)

0.0998

No. of injections, mean (SD)

4.7 (1.80)

4.2 (1.79)

4.4 (1.81)

0.0986

Aflibercept

78 (90.7)

107 (86.3)

185 (88.1)

0.3321

Ranibizumab

8 (9.3)

17 (13.7)

25 (11.9)

0.3321

  1. No DR, no diabetic retinopathy; Mild NPDR, mild nonproliferative diabetic retinopathy; Moderate NPDR, moderate nonproliferative diabetic retinopathy; Severe NPDR, severe nonproliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy; Focal laser, performed; Injection to OCT interval, in weeks; No. of injections, number of injections received; Aflibercept, patients received Aflipercept; Ranibizumab, patients received Ranibizumab